Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-1110 in Hunner Type Interstitial Cystitis
NCT06752603Phase 2Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Apr 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ONO-1110 in interstitial cystitis (IC), sponsored by Ono Pharmaceutical. Started Apr 2025; status: completed.
02
Drugs
ONO-1110
03
Conditions
interstitial cystitis (IC)
Beyond the preview
Go deeper on NCT06752603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06752603.